RD329 - Report on the Specialty Drug Program - November 2015


Executive Summary:
The 2015 Appropriation Act, Item 301 (S), requires:

"5. The department shall report on savings and quality improvements achieved through the implementation measures for the specialty drug program to the Chairmen of the House Appropriations and Senate Finance Committees, the Joint Commission on Health Care, and the Department of Planning and Budget by November 1 of each year."

This report responds to the requirement in Item 301 (S) (5) that the Department annually report on the cost savings and quality improvements achieved through the program. This report covers the fee-for-service specialty drug program. Specialty drugs are also provided through DMAS-contracted health plans for individuals enrolled in the managed care program. Specialty drug utilization in the health plans is not included in this report.